A poly(vinyl alcohol) nanoparticle platform for kinetic studies of inhaled particles

Inhalation Toxicology

Volumn 21, Issue 7, 2009, Pages 631-640

  Gul, Mine Orlu ^a,b   Jones, Stuart Allen ^a   Dailey, Lea Ann ^a   Nacer, Hadjer ^a   Ma, Yongmin ^a   Sadouki, Fethi ^a   Hider, Robert ^a   Araman, Ahmet ^b   Forbes, Ben ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BALANCED SALT SOLUTION; CARBOXYLIC ACID; FLUORESCENT DYE; LATEX; NANOPARTICLE; POLYVINYL ALCOHOL;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; INHALATION; KINETICS; PARTICLE SIZE; PRIORITY JOURNAL; PURIFICATION;

ADMINISTRATION, INHALATION; CELL LINE; HUMANS; NANOPARTICLES; PARTICULATE MATTER; POLYVINYL ALCOHOL;

EID: 70350608232     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958370802353435     Document Type: Article

References (39)

1. Bagchi, P. 1973. Theory of stabilization of spherical colloidal particles by nonionic polymers. J. Colloid Interface Sci. 47:86-99.
2. Buttini, F., Soltani, A., Colombo, P., Marriott, C., and Jones, S.A. 2008. Multilayer PVA adsorption onto hydrophobic drug substrates to engineer drug-rich microparticles. Eur. J. Pharm. Sci. 33:20-28.
3. Cartier, R., Kaufner, L., Paulke, B.R., Wustneck, R., Pietschmann, S., Michel, R., Bruhn, H., and Pison, U. 2007. Latex nanoparticles for multimodal imaging and Detection in vivo. Nanotech.18:1-12.
4. Chan, V.S.W. 2006. Nanomedicine: An unresolved regulatory issue. Regul. Toxicol. Pharmacol. 46:218-224.
5. Dailey, L.A., Jekel, N., Fink, L., Gessler, T., Schmehl, T., Wittmar, M., Kissel, T., and Seeger, W. 2006. Investigation of the proinflammatory potential of bioDegradable nanoparticle drug Delivery systems in the lung. Toxicol. Applied Pharmacol. 215:100-108.
6. Derjaguin, B.V., and Landau, V. 1941. Theory of the stability of strongly charged lyophobic soils and the adhesion of strongly charged particles in solutions of electrolytes. Acta Physiochem. U.R.S.S. 14:633-651.
7. Elmas, B., Tuncel, M., Yalçin, G., Şenel, S., and Tuncel, A. 2005. Synthesis of uniform, fluorescent poly(glycidyl methacrylate) based particles and their characterization by confocal laser scanning microscopy. Colloids and Surfaces A: Physicochem. Eng. Aspects 269:125-134.
8. Fessi, H., Puisieux, F., Devissaguet, J.P., Ammoury, N., and Benita, S. 1989. Nanocapsule formation by interfacial polymer Deposition following solvent displacement. Int. J. Pharm. 55:R1-R4.
9. Ficek, B.J., and Peppas, N.A. 1993. Novel preparation of poly(vinyl alcohol) microparticles without crosslinking agent for controlled drug Delivery of proteins. J. Control. Rel. 27:259-264.
10. Forbes, B. 2000. Human airway epithelial cell lines for in vitro drug transport and metabolism studies. P.S.T.T. 3:18-27.
11. Forbes, B., and Ehrhardt, C. 2005. Human respiratory epithelial cell culture for drug Delivery applications. Eur. J. Pharm. Biopharm. 60:193-205.
12. Geys, J., Coenegrachts, L., Vercammen, J., Engelborghs, Y., Nemmar, A., Nemery, B., and Hoet, P.H.M. 2006. In vitro study of the pulmonary translocation of NPs: A preliminary study. Toxicol. Letters 160:218-226.
13. Grainger, C., Greenwell, L.L., Lockley, D.J., Martin, G.P., and Forbes, B. 2006. Culture of Calu-3 cells at the air-liquid interface proviDes a representative moDel of the airway epithelial barrier. Pharm. Res. 23:1482-1490.
14. Grenha, A., Grainger, C., Dailey, L.A., Seijo, B., Martin, G.P., Remuñán-López, C., and Forbes, B. 2007. Chitosan nanoparticle-containing microspheres are compatible with respiratory epithelial cells in vitro. Eur. J. Pharm. Sci. 31:73-84.
15. Hiraku, O., and Yoshiharu, M. 1999. BioDegradation and distribution of watersoluble chitosan in mice. Biomaterials 20:175-182.
16. Hitzman, C.J., Elmquist, W.F., and Wiedmann, T.S. 2006. Development of a respirable, sustained release microcarrier for 5-fluorouracil II: In vitro and in vivo optimization of lipid coated nanoparticles. J. Pharm. Sci. 95:1127-1143.
17. Huang, M., Ma, Z., Khor, E., and Lim, L.Y. 2002. Uptake of FITC-chitosan NPs by A549 cells. Pharm. Res. 19:1488-1494.
18. Hyon, S.H., Cha, W.I., Ikada, Y., Kita, M., Ogura, Y., and Honda, Y. 1994. Poly(vinyl alcohol) hydrogels as soft contact lens material . J. Biomater. Sci. Polym. Ed. 5:397-406.
19. Kim, S., Lim, Y.S., Solyesz, E.G., De Grand, A.M., Lee, J., and Nakayama, A. 2004. Near infrared flurorescent type II quantum dots for sentinel lymph noDe mapping. Nat. Biotechnol. 22:92-97.
20. Jani, P.U., Florence, A.T., and Maccarthy, D.E. 1992. Further histological eviDence of the gastrointestinal absorption of polystyrene NPs in the rat. Int. J. Pharm. 84:245-252.
21. Jones, S.A., Martin, G.P., and Brown, M.B. 2005. High-pressure aerosol suspensions - A novel laser diffraction particle sizing system for hydrofluroalkane metered dose inhalers. Int. J. Pharm. 302:154-165.
22. Li, J.K., Wang, N., and Wu, X.S. 1998. Poly(vinyl alcohol) NPs prepared by freezing-thawing process for protein/peptiDe drug Delivery. J. Control. Rel. 56:117-126.
23. Limbach, L.K., Wick, P., Manser, P., Grass, R.N., Bruinink, A., and Stark, W.J. 2007. Exposure of engineered nanoparticles to human lung epithelial cells: Influence of chemical composition and catalytic activity on oxidative stress. Environ. Sci. Technol. 41:4158-4163.
24. Mathiowitz, E. 1999. Encyclopedia of Controlled Drug Delivery. Vol.1, pp. 607-608. New York: Wiley-Interscience.
25. Novoa, G.A.G., Heinamaki, J., Mirza, S., Antikainen, O., Colarte, A.I., Paz, A.S., and Yliruusi, J. 2005. Physical solid-state properties and dissolution of sustained release matrices of polyvinylacetate. Eur. J. Pharm. Biopharm. 59:343-350.
26. Oberdorster, G., Finklestein, J.N., Johnston, C., Gelein, R., Cox, C., and Baggs, R.M. 2000. Acute pulmonary effects of ultrafine particles in rats and mice. Res. Rep. Health. Eff. Inst. 96:5-74.
27. Oberdorster, G., Oberdorster, E., and Oberdorster, J. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Persp. 113:823-839.
28. Pashley, R.M. 1981. Hydration forces between mica surfaces in aqueous electrolyte solutions. J. Colloid Interface Science 83:531-546.
29. Reis, C.P., Neufeld, R.J., Ribeiro, A.J., and Veiga, F. 2006. Nanoencapsulation I. Methods for preparation of drug-loaDed polymeric NPs. Nanomed. Nanotech. Biol. Med. 2:8-21.
30. Rowe, R.C., Sheskey, P.J., and Weller, P.J. 2003. Polyvinyl alcohol. In Handbook of Pharmaceutical Excipients, eds. Rowe R.C., Weller P.J., Sheskey P.J., pp. 491-492. Bath: Pharmaceutical Press.
31. Sakagami, M. 2006. In vivo, in vitro and ex vivo moDels to assess pulmonary absorption and disposition of inhaled therapeutics for systemic Delivery. Adv. Drug Del. Rev. 58:1030-1060.
32. TeeguarDen, J.G., HinDerliter, P.M., Orr, G., Thrall, B.D., and Pounds, J.G. 2007. Particokinetics in vitro: Dosimetry consiDerations for in vitro nanoparticle toxicology assessments. Toxicol. Sci. 95:300-312.
33. Thanoo, B.C., Sunny, M.C., and Jayakrishnan, A. 1993. Controlled release of oral drugs from cross-linked polyvinyl alcohol microspheres. J. Pharm. Pharmacol. 45:16-20.
34. Verwey, E.J.W., and Overbeek, J.Th.G. 1948. Theory of stability of lyophilic colloids. Amsterdam: Elsevier.
35. Wang, F., Tan, W.B., Zhang, Y., Fan, X., and Wang, M. 2006. Luminescent nanomaterials for biological labeling. Nanotech. 17: R1-R13.
36. Weiss, B., Schaefer, U.F., Zapp, J., Lamprecht, A., Stallmach, A., and Lehr, C.M. 2006. Nanoparticle maDe of fluorescence-labeled poly(L-lactiDe-co- glycoliDe): Preparation, stability and biocompatibility. J. Nanosci. Nanotech. 6:3048-3056.
37. Wong, D., and Parasrampuria, J. 1996. Polyvinyl alcohol. In Analytical profiles of drug substances and excipients, ed. H.G. BrittainVol. 24, pp. 401-403. London: AcaDemic Press.
38. Worle-Knirsch, J.M., Pulskamp, K., and Krug, H.F. 2006. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nanoletters 6:1261-1268.
39. Yaghoobain, N., DeMaio, L., Xie, J., Hamm-Alvarez, S., Peng, C.A., Borok, Z., Crandall, E.D., and Kim, K.J. 2006 Nanoparticles can injure and translocate across alveolar epithelial cell monolayers. F.A.S.E.B. 20:A1439.